# Fortune Brands Innovations, Inc.: overview

FBIN · NYSE · CIK 1519751 · [Materials](/sectors/materials.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/fbin.md) · [Financials](/companies/fbin/financials.md) · [Filings](/companies/fbin/filings.md) · [Insiders](/companies/fbin/insiders.md)

Latest reported revenue: [$1.15bn](/filings/0001193125-26-335205.md) for Q2 FY2026, three months to 2026-06-27, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-335205).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,155](/filings/0001193125-25-258670.md) | [1,104 d](/filings/0001193125-26-063960.md) | [1,033](/filings/0001193125-26-211916.md) | [1,203](/filings/0001193125-26-335205.md) | [1,149](/filings/0001193125-25-258670.md) | [1,078 d](/filings/0001193125-26-063960.md) | [1,011](/filings/0001193125-26-211916.md) | [1,154](/filings/0001193125-26-335205.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [17.8%](/filings/0001193125-25-258670.md) | [16.1% d](/filings/0001193125-26-063960.md) | [9.4%](/filings/0001193125-26-211916.md) | [14.3%](/filings/0001193125-26-335205.md) | [11.0%](/filings/0001193125-25-258670.md) | [11.3% d](/filings/0001193125-26-063960.md) | [6.0%](/filings/0001193125-26-211916.md) | [(0.8%)](/filings/0001193125-26-335205.md) |
| Net margin | % | [11.8%](/filings/0001193125-25-258670.md) | [9.5% d](/filings/0001193125-26-063960.md) | [5.0%](/filings/0001193125-26-211916.md) | [8.3%](/filings/0001193125-26-335205.md) | [6.2%](/filings/0001193125-25-258670.md) | [7.1% d](/filings/0001193125-26-063960.md) | [2.4%](/filings/0001193125-26-211916.md) | [(1.9%)](/filings/0001193125-26-335205.md) |
| Diluted EPS | $ per share | [1.09](/filings/0001193125-25-258670.md) | not reported | [0.42](/filings/0001193125-26-211916.md) | [0.83](/filings/0001193125-26-335205.md) | [0.59](/filings/0001193125-25-258670.md) | not reported | [0.20](/filings/0001193125-26-211916.md) | [(0.19)](/filings/0001193125-26-335205.md) |
| Free cash flow | $m | [176 d](/filings/0001193125-25-258670.md) | [212 d](/filings/0001193125-26-063960.md) | [(113)](/filings/0001193125-26-211916.md) | [119 d](/filings/0001193125-26-335205.md) | [177 d](/filings/0001193125-25-258670.md) | [184 d](/filings/0001193125-26-063960.md) | [(140)](/filings/0001193125-26-211916.md) | [179 d](/filings/0001193125-26-335205.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2025-12-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,801](/filings/0000950170-24-021148.md) | [4,723](/filings/0000950170-25-026763.md) | [4,626](/filings/0001193125-26-063960.md) | [4,609](/filings/0001193125-26-063960.md) | [4,463](/filings/0001193125-26-063960.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [16.9%](/filings/0000950170-24-021148.md) | [16.4%](/filings/0000950170-25-026763.md) | [13.3%](/filings/0001193125-26-063960.md) | [16.0%](/filings/0001193125-26-063960.md) | [11.6%](/filings/0001193125-26-063960.md) |
| Net margin | % | [16.1%](/filings/0000950170-23-005127.md) | [14.5%](/filings/0000950170-23-005127.md) | [8.7%](/filings/0001193125-26-063960.md) | [10.2%](/filings/0001193125-26-063960.md) | [6.7%](/filings/0001193125-26-063960.md) |
| Diluted EPS | $ per share | [5.54](/filings/0000950170-24-021148.md) | [5.23](/filings/0000950170-25-026763.md) | [3.17](/filings/0001193125-26-063960.md) | [3.75](/filings/0001193125-26-063960.md) | [2.47](/filings/0001193125-26-063960.md) |
| Free cash flow | $m | [475](/filings/0000950170-24-021148.md) | [320](/filings/0000950170-25-026763.md) | [799](/filings/0001193125-26-063960.md) | [475](/filings/0001193125-26-063960.md) | [367](/filings/0001193125-26-063960.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fbin/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.06bn | 19,348,914 |  | Added +17,832 |
| [HARRIS ASSOCIATES L P](/funds/813917.md) | 2026-06-30 | $418.9m | 7,629,819 |  | Added +250,805 |
| [Pictet Asset Management Holding SA](/funds/1993888.md) | 2026-06-30 | $375.7m | 6,848,264 |  | Reduced −949,814 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $294.4m | 5,361,627 |  | Reduced −296,097 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $285.0m | 5,191,212 |  | Reduced −197,910 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $252.0m | 4,590,079 |  | Added +525,993 |
| [Garden Investment Management, L.P.](/funds/2044217.md) | 2026-06-30 | $216.6m | 3,944,999 |  | Added +417,391 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $210.1m | 3,826,061 |  | Added +43,853 |
| [First Pacific Advisors, LP](/funds/1377581.md) | 2026-06-30 | $210.0m | 3,825,269 |  | Added +33,039 |
| [Freestone Grove Partners LP](/funds/2007591.md) | 2026-06-30 | $136.1m | 2,478,374 |  | Added +1,089,422 |

## Recent filings

[All 1,358 filings](/companies/fbin/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:54 ET | [8-K](/filings/0001193125-26-434380.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-434380 |
| 2026-10-15 | 16:16 ET | [8-K](/filings/0001193125-26-422895.md) | 2.06 Material impairments; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-422895 |
| 2026-09-09 | 16:16 ET | [8-K](/filings/0001193125-26-386469.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-386469 |
| 2026-08-19 | 11:14 ET | [SCHEDULE 13D/A](/filings/0001361570-26-000014.md) | Ownership report, active investor, amended | 0001361570-26-000014 |
| 2026-08-05 | 16:21 ET | [10-Q](/filings/0001193125-26-335205.md) | Quarterly report, period 2026-06-27 | 0001193125-26-335205 |
| 2026-08-04 | 16:08 ET | [8-K](/filings/0001193125-26-332793.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332793 |
| 2026-08-04 | 11:30 ET | [SCHEDULE 13D/A](/filings/0001361570-26-000013.md) | Ownership report, active investor, amended | 0001361570-26-000013 |
| 2026-07-30 | 16:02 ET | [8-K](/filings/0001193125-26-326086.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-326086 |
| 2026-06-29 | 16:06 ET | [8-K/A](/filings/0001193125-26-288424.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-288424 |
| 2026-06-29 | 09:01 ET | [8-K](/filings/0001193125-26-286962.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-286962 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 27, 2025](/filings/0001193125-26-063960.md), filed Feb 23, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/61ab0922-bb76-4810-8911-018b615966c4)

## About the filer

- CIK: 1519751
- Tickers: FBIN
- Exchange: NYSE
- SIC code: 2430 Millwood, Veneer, Plywood, & Structural Wood Members
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:55 ET. No prices; not investment advice.